The change stems from the FTSE 100 drugmaker's $10.6bnTakeoverof Nuvalent, a US developer of targeted cancer drugs, which completed on 15 July 2026. Within a week the Food and Drug Administration had approved the first medicine from the deal. At its second-quarter results in …
Haleon (LSE:HLN), a FTSE 100 constituent, reported sequential improvement in the second quarter, a wider adjusted operating margin, double-digit growth in adjustedEarnings Per Shareand a higher interim dividend. It also reiterated its full-year guidance. The market was not fully convinced, however, and the shares …
Convatec (LSE:CTEC), the FTSE 100 constituent that specialises in chronic care products, published interim results on 4 August 2026. Organic growth excluding its troubled InnovaMatrix wound product was 5.0%, and the company narrowed its full-year guidance while pointing to 6% to 8% growth in …
On 14 September 2026, the FTSE 100 drugmaker and its partner Daiichi Sankyo presented full results from the DESTINY-Lung04 trial. Enhertu delivered a median progression-free survival of 14.3 months as a first-line treatment for HER2-mutant advanced non-small cell lung cancer, well ahead of the …
Oxford Biomedica became one of the most closely watched UK healthcare stocks on 22 September afterLSE:OXB climbed 6.02% to 493p. The move followed the company's interim results for the six months ended 30 June 2026, which highlighted continued revenue growth, record new-client activity and …
Oxford Nanopore Technologies (LSE:ONT) closed at178.00p on 22 September 2026, representing a3.37% gainfrom the previous close. The stock opened at 173.90p, touched a low of 173.60p and reached 178.00p, finishing at the day's high.Volumewas approximately 1.8 million shares.
Reckitt Benckiser Group PLC — LSE:RKT closed 1.19% higher on22 September 2026, with the shares at 5,038.00p after a gain of 59.00p on the day.
Smith & Nephew PLC — LSE:SN. closed 0.29% higher on22 September 2026, with the shares at 1,037.00p after a gain of 3.00p on the day.
Bunzl PLC — LSE:BNZL closed 1.53% higher on22 September 2026, with the shares at 2,654.00p after a gain of 40.00p on the day.
Croda International PLC — LSE:CRDA closed 0.87% higher on22 September 2026, with the shares at 3,237.00p after a gain of 28.00p on the day.